Search research articles
Contact Us
Filters
Showing results (31-40 of 157) with videos related to
Page
of 16
Sort By:
Seminars in Arthritis and Rheumatism
|
August 23, 2024
Clinical characteristics of idiopathic inflammatory myopathies patients with anti-PM/Scl antibodies
Longyang Zhu, Chen Zong, Yiran Chen, et al.
CNS Neuroscience & Therapeutics
|
May 15, 2026
Etiopathogenesis of Immune-Mediated Necrotizing Myopathy: A Comprehensive Review of Recent Advances
Chang Gao, Wenli Li, Qingyan Liu, et al.
Respiratory Medicine
|
July 26, 2019
Clinical characteristics of dermatomyositis patients with isolated anti-Ro-52 antibody associated rapid progressive interstitial lung disease: Data from the largest single Chinese center
Fang Chen, Yu Zuo, Shanshan Li, et al.
Biomicrofluidics
|
March 28, 2017
Evaluation of disposable microfluidic chip design for automated and fast Immunoassays
Guochun Wang, Champak Das, Bradley Ledden, et al.
Zhonghua Yi Xue Za Zhi
|
January 28, 2015
[Preventive therapy for iatrogenic active tuberculosis in systemic lupus erythematosus patients]
Li Ma, Bing Lin, Liying Wang, et al.
Annals of the Rheumatic Diseases
|
February 23, 2024
Novel endotypes of antisynthetase syndrome identified independent of anti-aminoacyl transfer RNA synthetase antibody specificity that improve prognostic stratification
Shiyu Wu, Xinyue Xiao, Yingfang Zhang, et al.
RMD Open
|
April 5, 2024
Dynamic change in red cell distribution width as a predictor for short-time mortality in dermatomyositis-associated rapid progressive interstitial lung disease
Fang Chen, Qiwen Jin, Yingfang Zhang, et al.
Frontiers in Medicine
|
February 4, 2022
Interstitial Lung Disease Is a Major Characteristic of Patients Who Test Positive for Anti-PM/Scl Antibody
Yongpeng Ge, Xiaoming Shu, Linrong He, et al.
Clinical Rheumatology
|
February 11, 2019
Serum YKL-40 level is associated with severity of interstitial lung disease and poor prognosis in dermatomyositis with anti-MDA5 antibody
Lili Jiang, Youlian Wang, Qinglin Peng, et al.
Clinical Rheumatology
|
January 7, 2021
Anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive dermatomyositis responds to rituximab therapy
Yongpeng Ge, Shanshan Li, Xiaolan Tian, et al.
Page
of 16
Search research articles
Search
Showing results (31-40 of 157) with videos related to
Sort By:
Page
of 16
Seminars in Arthritis and Rheumatism
|
August 23, 2024
Clinical characteristics of idiopathic inflammatory myopathies patients with anti-PM/Scl antibodies
Longyang Zhu, Chen Zong, Yiran Chen, et al.
CNS Neuroscience & Therapeutics
|
May 15, 2026
Etiopathogenesis of Immune-Mediated Necrotizing Myopathy: A Comprehensive Review of Recent Advances
Chang Gao, Wenli Li, Qingyan Liu, et al.
Respiratory Medicine
|
July 26, 2019
Clinical characteristics of dermatomyositis patients with isolated anti-Ro-52 antibody associated rapid progressive interstitial lung disease: Data from the largest single Chinese center
Fang Chen, Yu Zuo, Shanshan Li, et al.
Biomicrofluidics
|
March 28, 2017
Evaluation of disposable microfluidic chip design for automated and fast Immunoassays
Guochun Wang, Champak Das, Bradley Ledden, et al.
Zhonghua Yi Xue Za Zhi
|
January 28, 2015
[Preventive therapy for iatrogenic active tuberculosis in systemic lupus erythematosus patients]
Li Ma, Bing Lin, Liying Wang, et al.
Annals of the Rheumatic Diseases
|
February 23, 2024
Novel endotypes of antisynthetase syndrome identified independent of anti-aminoacyl transfer RNA synthetase antibody specificity that improve prognostic stratification
Shiyu Wu, Xinyue Xiao, Yingfang Zhang, et al.
RMD Open
|
April 5, 2024
Dynamic change in red cell distribution width as a predictor for short-time mortality in dermatomyositis-associated rapid progressive interstitial lung disease
Fang Chen, Qiwen Jin, Yingfang Zhang, et al.
Frontiers in Medicine
|
February 4, 2022
Interstitial Lung Disease Is a Major Characteristic of Patients Who Test Positive for Anti-PM/Scl Antibody
Yongpeng Ge, Xiaoming Shu, Linrong He, et al.
Clinical Rheumatology
|
February 11, 2019
Serum YKL-40 level is associated with severity of interstitial lung disease and poor prognosis in dermatomyositis with anti-MDA5 antibody
Lili Jiang, Youlian Wang, Qinglin Peng, et al.
Clinical Rheumatology
|
January 7, 2021
Anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive dermatomyositis responds to rituximab therapy
Yongpeng Ge, Shanshan Li, Xiaolan Tian, et al.
Page
of 16